TGaS scooped up in private acquisition

Share this article:
KnowledgePoint360 has acquired TGaS Advisors, provider of data and advice to pharma sales and marketing organizations.

Terms were not disclosed. TGaS will become an operating division of the company.

“TGaS offers a unique model of developing data to assist pharmaceutical companies in benchmarking their activities against those of [competitors],” Jon Bigelow, president and CEO of KnowledgePoint360, told MM&M.

KnowledgePoint360—whose other divisions support publication plans, speakers bureau logistics, disease-state education and other medical-communications services—was created after the 2007 acquisition of Thomson Medical Education (TME) by KnowledgePoint360's majority owner, private-equity firm ABRY Partners.

Last year the firm shuttered Postgraduate Professional Services (PPS), its accredited medical education arm.
Bigelow said his firm is still looking to expand. “We moved out of the CME business last year, but [in] just about any other area of healthcare information, we are interested in being suppliers if we see we can provide value.”

Separately, TGaS was slated to field the Pharmaceutical Marketing Research Group's first State of the Industry Survey at the PMRG Institute meeting in late October, as well as online. PMRG will present results next March at its Annual National Conference.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?